Improvement of cardiovascular risk prediction using coronary imaging: Subclinical atherosclerosis: The memory of lifetime risk factor exposure

European Heart Journal

Volumn 33, Issue 10, 2012, Pages 1201-1217

  Erbel, Raimund ^a   Budoff, Matthew ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Atherosclerosis; Coronary artery calcification; Coronary imaging; Prevention; Risk factors; Risk scores65

Indexed keywords

C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AGE; AIR POLLUTION; ALGORITHM; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHRONIC INFLAMMATION; CHRONIC KIDNEY DISEASE; CIGARETTE SMOKING; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE COURSE; HIGH RISK PATIENT; HUMAN; MULTIDETECTOR COMPUTED TOMOGRAPHY; PATIENT SAFETY; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCORING SYSTEM; SCREENING TEST; SEX; SOCIAL PSYCHOLOGY; SUDDEN DEATH; TRAFFIC; ULTRASOUND; X RAY;

EID: 84861373052     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs076     Document Type: Review

References (156)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011;123:e18-e209.
2. Stary HC. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. Eur Heart J 1990;11(Suppl. E): 3-19. (Pubitemid 20287937)
3. Fuster V, Cohen M, Halperin J. Aspirin in the prevention of coronary disease. N Engl J Med 1989;321:183-185. (Pubitemid 19180682)
4. Erbel R, Möhlenkamp S, Moebus S, Schmermund A, Lehmann N, Stang A, Dragano N, Grönemeyer D, Seibel R, Kälsch H, Bröcker-Preuss M, Mann K, Siegrist J, Jö ckel KH; Heinz Nixdorf Recall Study Investigative Group. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol 2010;56:1397-1406.
5. Thom TJ, Kannel WB, Silberhatz D, DÁ gostino RB Sr. Cardiovascular diseases in the United States and prevention approaches. In Fuster V, Alexander RW, Schlant RC, O'Rourke RA, Roberts R, Sonnenblick EH, (eds), Hurst's the Heart. 10th ed. New York, NY: McGraw Hill; 2001. p3-7.
6. Boland LL, Folsom AR, Sorlie PD, Taylor HA, Rosamond WD, Chambless LE, Cooper LS. Occurrence of unrecognized myocardial infarction in subjects aged 45-65 years (the ARIC study). Am J Cardiol 2002;90:927-931. (Pubitemid 35232613)
7. Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet 1999;353:89-92. (Pubitemid 29088076)
8. Löwel H, Meisinger C, Heier M, Hymer H, Alte D, Vö lzke H. Epidemiology of hypertension in Germany. Selected results of population-representative crosssectional studies. Dtsch Med Wochenschr 2006;131:2586-2591. (Pubitemid 44899498)
9. Dudas K, Lappas G, Stewart S, Rosengren A. Trends in out-of-hospital deaths due to coronary heart disease in Sweden (1991-2006). Circulation 2011;123: 46-52.
10. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345:1473-1482.
11. Fuster VV. Tribute to ronald W.F. Campbell, MBChB, MRCP, FRCP. Circulation 1998;98:2361-2362.
12. Losordo DW, Willerson JT. Jeffrey M Isner, MD. Circulation 2002;105:268-269.
13. Soler-Soler J. Philip Poole-Wilson. Rev Esp Cardiol 2009;62:703.
14. Dzau VJ, Molkentin JD. Helmut Drexler, MD, 1951-2009. Circulation 2009;120: 2402-2403.
15. Chambless L, Keil U, Dobson A, Mähönen M, Kuulasmaa K, Rajakangas AM, Löwel H, Tunstall-Pedoe H. Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985-1990. Multinational MONItoring of Trends and Determinants in CArdiovascular Disease. Circulation 1997;96:3849-3859.
16. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J 3rd. Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study. Ann Intern Med 1961;55:33-50.
17. Sytkowski PA, Kannel WB, D'Agostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med 1990;322:1635-1641. (Pubitemid 20171587)
18. Mozaffarian D, Wilson PW, Kannel WB. Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation 2008;117: 3031-3038.
19. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P; CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001;286: 180-187. (Pubitemid 32640849)
20. Kannel WB, Neaton JD, Wentworth D, Thomas HE, Stamler J, Hulley SB, Kjelsberg MO. Overall and coronary heart disease mortality rates in relation to major risk factors in 325 348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. Am Heart J 1986;112:825-836. (Pubitemid 16025049)
21. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-1847. (Pubitemid 28213628)
22. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation 2008;117:743-753. (Pubitemid 351640675)
23. Hense HW, Schulte H, Löwel H, Assmann G, Keil U. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany-results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J 2003;24:937-945. (Pubitemid 36559987)
24. Empana JP, Tafflet M, Escolano S, Vergnaux AC, Bineau S, Ruidavets JB, Montaye M, Haas B, Czernichow S, Balkau B, Ducimetiere P. Predicting CHD risk in France: a pooled analysis of the D.E.S.I.R., Three City, PRIME, and SU.VI.MAX studies. Eur J Cardiovasc Prev Rehabil 2011;18:175-185.
25. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
26. Assmann G, Schulte H, von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 1996;77:1179-1184. (Pubitemid 26186958)
27. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 2002;105:310-315. (Pubitemid 34106178)
28. Assmann G, Schulte H, Seedorf U. Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study. Int J Obes (Lond) 2008;32(Suppl. 2):S11-S16. (Pubitemid 351671296)
29. Wood D, de Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K. Prevention of coronary heart disease in clinical practice. Eur Heart J 1998;19: 1434-1503.
30. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A; European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG). European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 2007;28:2375-2414. (Pubitemid 47542237)
31. Keil U, Fitzgerald AP, Gohlke H, Wellmann J, Hense HW. Risikostratifikation mit den neuen ESC-Risikotabellen für Deutschland. Dtsch Ä rztebl 2005;102: A1808-A1812.
32. Gohlke H, Winter M, Karoff M, Held K. CARRISMA: a new tool to improve risk stratification and guidance of patients in cardiovascular risk management in primary prevention. Eur J Cardiovasc Prev Rehabil 2007;14:141-148.
33. Collins GS, Altman DG. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study. Br Med J 2009;339:b2584.
34. Collins GS, Altman DG. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. Br Med J 2010; 340:c2442.
35. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007;297:611-619.
36. Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds RiskScore for men. Circulation 2008;118:2243-2251.
37. Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratorybased versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet 2008;371:923-931. (Pubitemid 351375276)
38. Ferrario M, Chiodini P, Chambless LE, Cesana G, Vanuzzo D, Panico S, Sega R, Pilotto L, Palmieri L, Giampaoli S; CUORE Project Research Group. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol 2005;34:413-421. (Pubitemid 40645332)
39. Hartz I, Njølstad I, Eggen AE. Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001. Eur Heart J 2005;26:2673-2680. (Pubitemid 41746690)
40. Marques-Vidal P, Rodondi N, Bochud M, Pécoud A, Hayoz D, Paccaud F, Mooser V,Waeber G, Vollenweider P. Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland. Eur J Cardiovasc Prev Rehabil 2008;15: 402-408.
41. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364: 937-952. (Pubitemid 39208455)
42. WHO-Prevention of Cardiovascular Disease. Guidelines from the assessment and management of total cardiovascular risk. Geneva: WHO; 2007.
43. Silber S, Jarre F, Pittrow D, Klotsche J, Pieper L, Zeiher AM, Wittchen HU; DETECT-Studiengruppe. Cardiovascular risk assessment by primary-care physicians in Germany and its lack of agreement with the Established Risk Scores (DETECT). Med Klin (Munich) 2008;103:638-645.
44. Sniderman AD, Furberg CD. Age as a modifiable risk factor for cardiovascular disease. Lancet 2008;371:1547-1549.
45. Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ,Wolz M, Grundy SM, Johnson CL. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 2005;294:1773-1781. (Pubitemid 41434623)
46. Cooney MT, Dudina A, D'Agostino R, Graham IM. Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future? Circulation 2010;122:300-310.
47. Edgren JG. Die Arteriosklerose. Klinische Studien. Veit & Comp, Leipzig; 1898, 14.
48. Lobstein JF. Lehrbuch der pathologischen Anatomie. Stuttgart: 1835; Bd II:465.
49. Virchow R (ed.). Lebert in Handbuch der speziellen Pathologie und Therapie. 1861; Bd5:2:9.
50. Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH, Crouse JR 3rd, Friedman L, Fuster V, Herrington DM, Kuller LH, Ridker PM, Roberts WC, StanfordW, Stone N, Swan HJ, Taubert KA,Wexler L. Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 2000;101:E16-E22.
51. Greenland P, Smith SC Jr, Grundy SM. Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation 2001;104:1863-1867. (Pubitemid 32963355)
52. Pasternak RC, Abrams J, Greenland P, Smaha LA, Wilson PW, Houston-Miller N. 34th Bethesda Conference: Task force #1-identification of coronary heart disease risk: is there a detection gap? J Am Coll Cardiol 2003;41:1863-1874.
53. Blaha M, Budoff MJ, Shaw LJ, Khosa F, Rumberger JA, Berman D, Callister T, Raggi P, Blumenthal RS, Nasir K. Absence of coronary artery calcification and all-cause mortality. JACC Cardiovasc Imaging 2009;2:692-700.
54. Enos WF, Holmes RH, Beyer J. Coronary disease among United States soldiers killed in action in Korea; preliminary report. J Am Med Assoc 1953;152: 1090-1093.
55. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 1989;9(1 Suppl):I19-I32. (Pubitemid 19046963)
56. Feinleib M, Kannel WB, Tedeschi CG, Landau TK, Garrison RJ. The relation of antemortem characteristics to cardiovascular findings at necropsy-The Framingham Study. Atherosclerosis 1979;34:145-157. (Pubitemid 10245780)
57. Holme I, Solberg LA, Weissfeld L, Helgeland A, Hjermann I, Leren P, Strong JP, Williams OD. Coronary risk factors and their pathway of action through coronary raised lesions, coronary stenoses and coronary death. Multivariate statistical analysis of an autopsy series: the Oslo Study. Am J Cardiol 1985;55:40-47. (Pubitemid 15152519)
58. Solberg LA, Strong JP, Holme I, Helgeland A, Hjermann I, Leren P, Mogensen SB. Stenoses in the coronary arteries. Relation to atherosclerotic lesions, coronary heart disease, and risk factors. The Oslo Study. Lab Invest 1985;53:648-653.
59. Sorlie PD, Garcia-Palmieri MR, Castillo-Staab MI, Costas R Jr, Oalmann MC, Havlik R. The relation of antemortem factors to atherosclerosis at autopsy. The Puerto Rico Heart Health Program. Am J Pathol 1981;103:345-352. (Pubitemid 11064737)
60. Okumiya N, Tanaka K, Ueda K, Omae T. Coronary atherosclerosis and antecedent risk factors: pathologic and epidemiologic study in Hisayama, Japan. Am J Cardiol 1985;56:62-66. (Pubitemid 15069288)
61. Reed DM, MacLean CJ, Hayashi T. Predictors of atherosclerosis in the Honolulu Heart Program. I. Biologic, dietary, and lifestyle characteristics. Am J Epidemiol 1987;126:214-225. (Pubitemid 17102749)
62. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995;92:1355-1374.
63. Schmermund A, Baumgart D, Görge G, Seibel R, Grönemeyer D, Ge J, Haude M, Rumberger J, Erbel R. Coronary artery calcium in acute coronary syndromes: a comparative study of electron-beam computed tomography, coronary angiography, and intracoronary ultrasound in survivors of acute myocardial infarction and unstable angina. Circulation 1997;96:1461-1469. (Pubitemid 27375337)
64. Schmermund A, Mö hlenkamp S, Baumgart D, Kriener P, Pump H, Grönemeyer D, Seibel R, Erbel R. Usefulness of topography of coronary calcium by electron-beam computed tomography in predicting the natural history of coronary atherosclerosis. Am J Cardiol 2000;86:127-132. (Pubitemid 30410718)
65. Montenegro MR, Eggen DA. Topography of atherosclerosis in the coronary arteries. Lab Invest 1968;18:586-593.
66. Strong JP. Atherosclerotic lesions. Natural history, risk factors, and topography. Arch Pathol Lab Med 1992;116:1268-1275.
67. Halon DA, Sapoznikov D, Lewis BS, Gotsman MS. Localization of lesions in the coronary circulation. Am J Cardiol 1983;52:921-926. (Pubitemid 14227636)
68. Klein U, Locher D, Silber S. Röntgendiagnostische und nuklearmedizinische Untersuchungen im Deutschen Herzzentrum München. Herz 1976;1:108-117.
69. Detrano R, Salcedo EE, Hobbs RE, Yiannikas J. Cardiac cinefluoroscopy as an inexpensive aid in the diagnosis of coronary artery disease. Am J Cardiol 1986;57: 1041-1046. (Pubitemid 16020899)
70. Budoff MJ, Achenbach S, Blumenthal RS, Carr JJ, Goldin JG, Greenland P, Guerci AD, Lima JA, Rader DJ, Rubin GD, Shaw LJ, Wiegers SE; American Heart Association Committee on Cardiovascular Imaging and Intervention; American Heart Association Council on Cardiovascular Radiology and Intervention; American Heart Association Committee on Cardiac Imaging, Council on Clinical Cardiology. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 2006;114:1761-1791. (Pubitemid 44607126)
71. Hunold P, Vogt FM, Schmermund A, Debatin JF, Kerkhoff G, Budde T, Erbel R, Ewen K, Barkhausen J. Radiation exposure during cardiac CT: effective doses at multi-detector row CT and electron-beam CT. Radiology 2003;226:145-152. (Pubitemid 36163922)
72. Oudkerk M, Stillman AE, Halliburton SS, Kalender WA, Möhlenkamp S, McCollough CH, Vliegenthart R, Shaw LJ, Stanford W, Taylor AJ, van Ooijen PM, Wexler L, Raggi P; European Society of Cardiac Radiology; North American Society for Cardiovascular Imaging. Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging. Eur Radiol 2008;18:2785-2807.
73. Busch S, Johnson TR, Nikolaou K, von Ziegler F, Knez A, Reiser MF, Becker CR. Visual and automatic grading of coronary artery stenoses with 64-slice CT angiography in reference to invasive angiography. Eur Radiol 2007;17:1445-1451. (Pubitemid 46767592)
74. Achenbach S, Goroll T, Seltmann M, Pflederer T, Anders K, Ropers D, Daniel WG, Uder M, Lell M, Marwan M. Detection of coronary artery stenoses by low-dose, prospectively ECG-triggered, high-pitch spiral coronary CT angiography. JACC Cardiovasc Imaging 2011;4:328-337.
75. Choi TY, Malpeso J, Li D, Sourayanezhad S, Budoff MJ. Radiation dose reduction with increasing utilization of prospective gating in 64-multidetector cardiac computed tomography angiography. J Cardiovasc Comput Tomogr 2011;5:264-270.
76. Voros S, Rivera JJ, Berman DS, Blankstein R, Budoff MJ, Cury RC, Desai MY, Dey D, Halliburton SS, Hecht HS, Nasir K, Santos RD, Shapiro MD, Taylor AJ, Valeti US, Young PM, Weissman G; Society for Atherosclerosis Imaging and Prevention Tomographic Imaging and Prevention Councils; Society of Cardiovascular Computed Tomography. Guideline for minimizing radiation exposure during acquisition of coronary artery calcium scans with the use of multidetector computed tomography: a report by the Society for Atherosclerosis Imaging and Prevention Tomographic Imaging and Prevention Councils in collaboration with the Society of Cardiovascular Computed Tomography. J Cardiovasc Comput Tomogr 2011;5:75-83.
77. Hausleiter J, Martinoff S, Hadamitzky M, Martuscelli E, Pschierer I, Feuchtner GM, Catalán-Sanz P, Czermak B, Meyer TS, Hein F, Bischoff B, Kuse M, Schömig A, Achenbach S. Image quality and radiation exposure with a low tube voltage protocol for coronary CT angiography results of the PROTECTION II Trial. JACC Cardiovasc Imaging 2010;3:1113-1123.
78. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-832. (Pubitemid 20101575)
79. Callister TQ, Cooil B, Raya SP, Lippolis NJ, Russo DJ, Raggi P. Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology 1998;208:807-814. (Pubitemid 28405121)
80. Brown ER, Kronmal RA, Bluemke DA, Guerci AD, Carr JJ, Goldin J, Detrano R. Coronary calcium coverage score: determination, correlates, and predictive accuracy in the Multi-Ethnic Study of Atherosclerosis. Radiology 2008;247: 669-675.
81. Schmermund A, Pump H, Möhlenkamp S, Stang A, Grönemeyer D, Seibel R, Erbel R für die Heinz Nixdorf Studiengruppe. Nachweis einer exzellenten Befundu ̈bereinstimmung (K 0.94) der Koronarkalkmessung mittels Elektronenstrahltomographie in der Heinz Nixdorf Recall Studie. Z Kardiol 2003;92:I/385.
82. Detrano RC, Anderson M, Nelson J,Wong ND, Carr JJ, McNitt-Gray M, Bild DE. Coronary calcium measurements: effect of CT scanner type and calcium measure on rescan reproducibility-MESA study. Radiology 2005;236:477-484. (Pubitemid 41023428)
83. Ovrehus KA, Marwan M, Bøtker HE, Achenbach S, Nørgaard BL. Reproducibility of coronary plaque detection and characterization using low radiation dose coronary computed tomographic angiography in patients with intermediate likelihood of coronary artery disease (ReSCAN study). Int J Cardiovasc Imaging 2011 [Epub ahead of print].
84. Reinsch N, Mahabadi A, Lehmann N, Möhlenkamp S, Hoefs C, Sievers B, Budde T, Seibel R, Jö ckel KH, Erbel R. Comparison of dual-source and electron beam computed tomography for the assessment of coronary artery calcium scoring. Br J Radiol 2011; [Epub ahead of print].
85. Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, Lauer MS, Post WS, Raggi P, Redberg RF, Rodgers GP, Shaw LJ, Taylor AJ, Weintraub WS; American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography); Society of Atherosclerosis Imaging and Prevention; Society of Cardiovascular Computed Tomography. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2007;49: 378-402.
86. Erbel R, Möhlenkamp S, Kerkhoff G, Budde T, Schmermund A. Non-invasive screening for coronary artery disease: calcium scoring. Heart 2007;93: 1620-1629. (Pubitemid 350205568)
87. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S, Szklo M, Bluemke DA, O'Leary DH, Tracy R, Watson K, Wong ND, Kronmal RA. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008;358:1336-1345. (Pubitemid 351468410)
88. Elias-Smale SE, Proença RV, Koller MT, Kavousi M, van Rooij FJ, Hunink MG, Steyerberg EW, Hofman A, Oudkerk M, Witteman JC. Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study. J Am Coll Cardiol 2010;56:1407-1414.
89. McClelland RL, Chung H, Detrano R, Post W, Kronmal RA. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2006;113:30-37. (Pubitemid 43958485)
90. Erbel R, Delaney JA, Lehmann N, McClelland RL, Möhlenkamp S, Kronmal RA, Schmermund A, Moebus S, Dragano N, Stang A, Jö ckel KH, Budoff MJ; Multi-Ethnic Study of Atherosclerosis; Investigator Group of the Heinz Nixdorf Recall Study. Signs of subclinical coronary atherosclerosis in relation to risk factor distribution in the Multi-Ethnic Study of Atherosclerosis (MESA) and the Heinz Nixdorf Recall Study (HNR). Eur Heart J 2008;29:2782-2791.
91. Erbel R, Möhlenkamp S, Lehmann N, Schmermund A, Moebus S, Stang A, Grönemeyer D, Seibel R, Mann K, Volbracht L, Dragano N, Siegrist J, Jö ckel KH; Heinz Nixdorf Recall Study Investigative Group. Sex related cardiovascular risk stratification based on quantification of atherosclerosis and inflammation. Atherosclerosis 2008;197:662-672. (Pubitemid 351419239)
92. Loria CM, Liu K, Lewis CE, Hulley SB, Sidney S, Schreiner PJ, Williams OD, Bild DE, Detrano R. Early adult risk factor levels and subsequent coronary artery calcification: the CARDIA Study. J Am Coll Cardiol 2007;49:2013-2020. (Pubitemid 46734638)
93. Bild DE, Detrano R, Peterson D, Guerci A, Liu K, Shahar E, Ouyang P, Jackson S, Saad MF. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2005;111:1313-1320. (Pubitemid 40389097)
94. Schmermund A, Lehmann N, Bielak LF, Yu P, Sheedy PF 2nd, Cassidy-Bushrow AE, Turner ST, Moebus S, Möhlenkamp S, Stang A, Mann K, Jö ckel KH, Erbel R, Peyser PA. Comparison of subclinical coronary atherosclerosis and risk factors in unselected populations in Germany and US-America. Atherosclerosis 2007;195:e207-e216. (Pubitemid 47566387)
95. Schmermund A, Möhlenkamp S, Berenbein S, Pump H, Moebus S, Roggenbuck U, Stang A, Seibel R, Grönemeyer D, Jö ckel KH, Erbel R. Population-based assessment of subclinical coronary atherosclerosis using electron-beam computed tomography. Atherosclerosis 2006;185:177-182. (Pubitemid 43117566)
96. Jö ckel KH, Lehmann N, Jäger BR, Moebus S, Möhlenkamp S, Schmermund A, Dragano N, Stang A, Grönemeyer D, Seibel R, Mann K, Volbracht L, Siegrist J, Erbel R. Smoking cessation and subclinical atherosclerosis- results from the Heinz Nixdorf Recall Study. Atherosclerosis 2009;203:221-227.
97. Shaw LJ, Raggi P, Berman DS, Callister TQ. Coronary artery calcium as a measure of biologic age. Atherosclerosis 2006;188:112-119. (Pubitemid 44142526)
98. Peinemann F, Moebus S, Dragano N, Möhlenkamp S, Lehmann N, Zeeb H, Erbel R. Calcification among non-smoking participants of a population-based cohort. Environ Health Perspect 2011 [Epub ahead of print].
99. Moebus S, Stang A, Möhlenkamp S, Dragano N, Schmermund A, Slomiany U, Hoffmann B, Bauer M, Broecker-Preuss M, Mann K, Siegrist J, Erbel R, Jö ckel KH; Heinz Nixdorf Recall Study Group. Association of impaired fasting glucose and coronary artery calcification as a marker of subclinical atherosclerosis in a population-based cohort-results of the Heinz Nixdorf Recall Study. Diabetologia 2009;52:81-89.
100. Churzidse S, Möhlenkamp N, Lehmann U, Roggenbuck S, Moebus A, Schmermund N, Dragano A, Stang D, Grönemeyer R, Seibel K-H, Jö ckel R. Erbel Geschlechts-und Altersabhängigkeit der subklinischen koronaren Atherosklerose vom Schweregrad der arteriellen Hypertonie unter Berücksichtigung der Medikation-Heinz Nixdorf Recall Studie. Clin Res Cardiol 2008;97(Suppl. 1).
101. Erbel R, Lehmann N, Möhlenkamp S, Churzidse S, Bauer M, Kälsch H, Schmermund A, Moebus S, Stang A, Roggenbuck U, Bröcker-Preuß M, Dragano N,Weimar C, Siegrist J, Jö ckel KH. Subclinical coronary atherosclerosis predicts cardiovascular risk in different stages of hypertension-result of the Heinz Nixdorf Recall Study. Hypertension 2012;59:44-53.
102. Dragano N, Verde PE, Moebus S, Stang A, Schmermund A, Roggenbuck U, Möhlenkamp S, Peter R, Jö ckel KH, Erbel R, Siegrist J; Heinz Nixdorf Recall Study. Subclinical coronary atherosclerosis is more pronounced in men and women with lower socio-economic status: associations in a population-based study. Coronary atherosclerosis and social status. Eur J Cardiovasc Prev Rehabil 2007;14:568-574. (Pubitemid 47229739)
103. Dragano N, Hoffmann B, Stang A, Moebus S, Verde PE, Weyers S, Möhlenkamp S, Schmermund A, Mann K, Jö ckel KH, Erbel R, Siegrist J; Heinz Nixdorf Recall Study Investigative Group. Subclinical coronary atherosclerosis and neighbourhood deprivation in an urban region. Eur J Epidemiol 2009;24: 25-35.
104. Stang A, Dragano N, Poole C, Moebus S, Möhlenkamp S, Schmermund A, Siegrist J, Erbel R, Jö ckel KH. Daily siesta, cardiovascular risk factors, and measures of subclinical atherosclerosis: results of the Heinz Nixdorf Recall Study. Sleep 2007;30:1111-1119. (Pubitemid 47378955)
105. Hoffmann B, Moebus S, Stang A, Beck EM, Dragano N, Möhlenkamp S, Schmermund A, Memmesheimer M, Mann K, Erbel R, Jö ckel KH; Heinz Nixdorf RECALL Study Investigative Group. Residence close to high traffic and prevalence of coronary heart disease. Eur Heart J 2006;27:2696-2702. (Pubitemid 44729871)
106. Hoffmann B, Moebus S, Möhlenkamp S, Stang A, Lehmann N, Dragano N, Schmermund A, Memmesheimer M, Mann K, Erbel R, Jö ckel KH; Heinz Nixdorf Recall Study Investigative Group. Residential exposure to traffic is associated with coronary atherosclerosis. Circulation 2007;116:489-496. (Pubitemid 47450257)
107. Dragano N, Hoffmann B, Moebus S, Möhlenkamp S, Stang A, Verde PE, Jö ckel KH, Erbel R, Siegrist J; Heinz Nixdorf Recall Study Investigative Group. Traffic exposure and subclinical cardiovascular disease: is the association modified by socioeconomic characteristics of individuals and neighbourhoods? Results from a multilevel study in an urban region. Occup Environ Med 2009; 66:628-635.
108. Hertel S, Viehmann A, Moebus S, Mann K, Bröcker-Preuss M, Möhlenkamp S, Nonnemacher M, Erbel R, Jakobs H, Memmesheimer M, Jö ckel KH, Hoffmann B. Influence of short-term exposure to ultrafine and fine particles on systemic inflammation. Eur J Epidemiol 2010;25:581-592.
109. Fuks K, Moebus S, Hertel S, Viehmann A, Nonnemacher M, Dragano N, Möhlenkamp S, Jakobs H, Kessler C, Erbel R, Hoffmann B; Heinz Nixdorf Recall Study Investigative Group. Long-term urban particulate air pollution, traffic noise and arterial blood pressure. Environ Health Perspect 2011 [Epub ahead of print].
110. Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. Eur Heart J 2007;28: 1374-1381. (Pubitemid 47355969)
111. Möhlenkamp S, Lehmann N, Moebus S, Schmermund A, Dragano N, Stang A, Siegrist J, Mann K, Jö ckel KH, Erbel R; Heinz Nixdorf Recall Study Investigators. Quantification of coronary atherosclerosis and inflammation to predict coronary events and all-cause mortality. J Am Coll Cardiol 2011;57:1455-1464.
112. Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engström G, Persson M, Smith JG, Magnusson M, Christensson A, Struck J, Morgenthaler NG, Bergmann A, Pencina MJ, Wang TJ. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 2009;302: 49-57.
113. Cushman M, McClelland R, Folson A, Pamela Q, Blumenthal R, Detrano R, Post W, Goff D, Barr G, Liu K, Tracy R. Inflammation factors, coronary calcium and risk of cardiovascular events: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2007;116:II829.
114. Rho YH, Chung CP, Oeser A, Solus JF, Gebretsadik T, Shintani A, Raggi P, Milne GL, Stein CM. Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2010;62:1473-1480.
115. Nakamura S, Ishibashi-Ueda H, Niizuma S, Yoshihara F, Horio T, Kawano Y. Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol 2009;4:1892-1900.
116. Cianciolo G, La Manna G, Donati G, Persici E, Dormi A, Cappuccilli ML, Corsini S, Fattori R, Russo V, Nastasi V, Col?̀ L, Wratten M, Stefoni S. Coronary calcifications in end-stage renal disease patients: a new link between osteoprotegerin, diabetes and body mass index? Blood Purif 2010;29:13-22.
117. Stavroulopoulos A, Porter CJ, Pointon K, Monaghan JM, Roe SD, Cassidy MJ. Evolution of coronary artery calcification in patients with chronic kidney disease Stages 3 and 4, with and without diabetes. Nephrol Dial Transplant 2011;26:2582-2589.
118. Budoff MJ, Rader DJ, Reilly MP, Mohler ER 3rd, Lash J, Yang W, Rosen L, Glenn M, Teal V, Feldman HI; CRIC Study Investigators. Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis 2011;58:519-526.
119. Wayhs R, Zelinger A, Raggi P. High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol 2002;39:225-230. (Pubitemid 34084625)
120. Möhlenkamp S, Lehmann N, Schmermund A, Pump H, Moebus S, Baumgart D, Seibel R, Grönemeyer DH, Jö ckel KH, Erbel R. Prognostic value of extensive coronary calcium quantities in symptomatic males-a 5-year follow-up study. Eur Heart J 2003;24:845-854. (Pubitemid 36528564)
121. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR Jr, Kronmal R, Liu K, Nelson JC, O'Leary D, Saad MF, Shea S, Szklo M, Tracy RP. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002;156:871-881. (Pubitemid 35215769)
122. Schmermund A, Möhlenkamp S, Stang A, Grönemeyer D, Seibel R, Hirche H, Mann K, Siffert W, Lauterbach K, Siegrist J, Jö ckel KH, Erbel R. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. Am Heart J 2002;144: 212-218. (Pubitemid 34879641)
123. Budoff MJ, Nasir K, McClelland RL, Detrano R, Wong N, Blumenthal RS, Kondos G, Kronmal RA. Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2009;53:345-352.
124. Erratum in: J Am Coll Cardiol 2009;53:1474.
125. Vliegenthart R, Oudkerk M, Hofman A, Oei HH, van Dijck W, van Rooij FJ, Witteman JC. Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation 2005;112:572-577. (Pubitemid 41060798)
126. Schmermund A, Erbel R. Unstable coronary plaque and its relation to coronary calcium. Circulation 2001;104:1682-1687. (Pubitemid 32947534)
127. Shareghi S, Ahmadi N, Young E, Gopal A, Liu ST, Budoff MJ. Prognostic significance of zero coronary calcium scores on cardiac computed tomography. J Cardiovasc Comput Tomogr 2007;1:155-159. (Pubitemid 350186350)
128. Taylor AJ, Raggi J, Raggi P. The power of nothing: the zero calcium score. J Cardiovasc Comput Tomogr 2007;1:160-161. (Pubitemid 350186351)
129. Raggi P, Gongora MC, Gopal A, Callister TQ, Budoff M, Shaw LJ. Coronary artery calcium to predict all-cause mortality in elderly men and women. J Am Coll Cardiol 2008;52:17-23. (Pubitemid 351858598)
130. Sarwar A, Shaw LJ, Shapiro MD, Blankstein R, Hoffmann U, Cury RC, Abbara S, Brady TJ, Budoff MJ, Blumenthal RS, Nasir K. Diagnostic and prognostic value of absence of coronary artery calcification. JACC Cardiovasc Imaging 2009;2: 675-688.
131. Blaha MJ, Blumenthal RS, Budoff MJ, Nasir K. Understanding the utility of zero coronary calcium as a prognostic test: a Bayesian approach. Circ Cardiovasc Qual Outcomes 2011;4:253-256.
132. Min JK, Shaw LJ, Berman DS. The present state of coronary computed tomography angiography a process in evolution. J Am Coll Cardiol 2010;55:957-965.
133. Min JK, Lin FY, Gidseg DS, Weinsaft JW, Berman DS, Shaw LJ, Rozanski A, Callister TQ. Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the 'warranty period' for remaining normal? J Am Coll Cardiol 2010;55:1110-7.
134. Hecht HS. A zero coronary artery calcium score: priceless. J Am Coll Cardiol 2010;55:1118-1120.
135. Arad Y, Spadaro LA, Roth M, Newstein D, Guerci AD. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. J Am Coll Cardiol 2005;46:166-172. (Pubitemid 40905146)
136. Schmermund A, Achenbach S, Budde T, Buziashvili Y, Fö rster A, Friedrich G, Henein M, Kerkhoff G, Knollmann F, Kukharchuk V, Lahiri A, Leischik R, Moshage W, Schartl M, Siffert W, Steinhagen-Thiessen E, Sinitsyn V, Vogt A, Wiedeking B, Erbel R. Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial. Circulation 2006; 113:427-437. (Pubitemid 43803205)
137. Schmermund A, Baumgart D, Möhlenkamp S, Kriener P, Pump H, Grönemeyer D, Seibel R, Erbel R. Natural history and topographic pattern of progression of coronary calcification in symptomatic patients: an electron-beam CT study. Arterioscler Thromb Vasc Biol 2001;21:421-426. (Pubitemid 32199125)
138. Maher JE, Bielak LF, Raz JA, Sheedy PF 2nd, Schwartz RS, Peyser PA. Progression of coronary artery calcification: a pilot study. Mayo Clin Proc 1999;74:347-355. (Pubitemid 29162534)
139. Budoff MJ, Lane KL, Bakhsheshi H, Mao S, Grassmann BO, Friedman BC, Brundage BH. Rates of progression of coronary calcium by electron beam tomography. Am J Cardiol 2000;86:8-11. (Pubitemid 30365135)
140. Yoon HC, Emerick AM, Hill JA, Gjertson DW, Goldin JG. Calcium begets calcium: progression of coronary artery calcification in asymptomatic subjects. Radiology 2002;224:236-241. (Pubitemid 34680400)
141. Raggi P, Cooil B, Ratti C, Callister TQ, Budoff M. Progression of coronary artery calcium and occurrence of myocardial infarction in patients with and without diabetes mellitus. Hypertension 2005;46:238-243. (Pubitemid 40946521)
142. Hokanson JE, MacKenzie T, Kinney G, Snell-Bergeon JK, Dabelea D, Ehrlich J, Eckel RH, Rewers M. Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability. J Am Coll Cardiol Am J Roentgenol 2004;182:1327-1332. (Pubitemid 38525535)
143. O'Rourke RA, Brundage BH, Froelicher VF, Greenland P, Grundy SM, Hachamovitch R, Pohost MG, Shaw LJ, Weintraub WS, Winters WL. American College of Cardiology/American Heart Association Expert Consensus Document on Electron-Beam Computed Tomograph for the Diagnosis and Prognosis of Coronary Artery Disease. J Am Coll Cardiol 2000;36:326-340. (Pubitemid 30466157)
144. Bansal S, Blumenthal RS. Total coronary artery calcium score remains preferred metric to refine risk prediction in nearly all patients. JACC Cardiovasc Imaging 2008;1:70-72.
145. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC Jr, Taylor AJ, Weintraub WS, Wenger NK, Jacobs AK, Smith SC Jr, Anderson JL, Albert N, Buller CE, Creager MA, Ettinger SM, Guyton RA, Halperin JL, Hochman JS, Kushner FG, Nishimura R, Ohman EM, Page RL, Stevenson WG, Tarkington LG, Yancy CW; American College of Cardiology Foundation; American Heart Association. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010;56:e50-e103.
146. Polonsky TS, McClelland RL, Jorgensen NW, Bild DE, Burke GL, Guerci AD, Greenland P. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 2010;303:1610-1616.
147. Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol 2005;46: 158-165. (Pubitemid 40905145)
148. Kim KP, Einstein AJ, Berrington de González A. Coronary artery calcification screening: estimated radiation dose and cancer risk. Arch Intern Med 2009;169: 1188-1194.
149. Gerber TC, Gibbons RJ. Weighing the risks and benefits of cardiac imaging with ionizing radiation. JACC Cardiovasc Imaging 2010;3:528-535.
150. Brenner DJ, Doll R, Goodhead DT, Hall EJ, Land CE, Little JB, Lubin JH, Preston DL, Preston RJ, Puskin JS, Ron E, Sachs RK, Samet JM, Setlow RB. Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci USA 2003;100:13761-13766. (Pubitemid 37499140)
151. O'Malley PG, Feuerstein IM, Taylor AJ. Impact of Electron Beam Tomography, With or Without Case Management, on Motivation, Behavioral Change, and Cardiovascular Risk Profile: A Randomized Controlled Trial. JAMA 2003;289: 2215-2223. (Pubitemid 37430189)
152. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003;108:1664-1672. (Pubitemid 37243650)
153. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 2003;108:1772-1778. (Pubitemid 37296082)
154. Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, Fayad Z, Budoff MJ, Rumberger J, Naqvi TZ, Shaw LJ, Faergeman O, Cohn J, Bahr R, Koenig W, Demirovic J, Arking D, Herrera VL, Badimon J, Goldstein JA, Rudy Y, Airaksinen J, Schwartz RS, Riley WA, Mendes RA, Douglas P, Shah PK; SHAPE Task Force. From vulnerable plaque to vulnerable patient-part III: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol 2006;98:2H-15H.
155. Sillesen H, Falk E. Why not screen for subclinical atherosclerosis? Lancet 2011; 378:645-646.
156. Shah PK. Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should we? J Am Coll Cardiol 2010;56:98-105.